CollPlant Biotechnologies
OPHI · NASDAQ
$3.65+$3.65 (+0.00%)TodayMarket closed ·
Prev close $0.00
Key indicators
OPHI profitability and balance sheet ratios
EPS -$0.2926 in Dec 2012, against -$0.2571 a year earlier.
| Period | EPS |
|---|---|
| Mar 2011 | -$0.0574 |
| Jun 2011 | -$0.1237 |
| Sep 2011 | -$0.0902 |
| Dec 2011 | -$0.2571 |
| Mar 2012 | -$0.0237 |
| Jun 2012 | -$0.3555 |
| Sep 2012 | -$0.3059 |
| Dec 2012 | -$0.2926 |
Income statement
No financial statements are reported for CollPlant Biotechnologies.
Balance sheet
What the company owns and owes at period end
Total assets
Total liabilities
| Line item | Jun 2012 | Sep 2012 | Dec 2012 |
|---|---|---|---|
| Total assets | $0.2M | $0.3M | $0.2M |
| Total liabilities | $0.9M | $1.0M | $1.1M |
| Shareholder equity | −$0.7M | −$0.7M | −$0.9M |
| Cash and short-term investments | $0.0M | $0.1M | $0.0M |
| Total debt | $0.5M | $0.5M | $0.4M |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.